A Phase 3 interventional study of PBK_M2502 1-Day and PBK_M2502 2-Day in Intestinal Disease, Colonic Diseases and Gastrointestinal Disease, sponsored by Pharmbio Korea Co., Ltd.. Not yet recruiting at 1 site in South Korea. Open to participants aged 19 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-11.
Sponsored by Pharmbio Korea Co., Ltd. · Phase 3, Interventional, and Diagnostic
This clinical trial was prospective, randomized, single-blind, 3-treatment arm, parallel treatment group, and active-controlled. , Multi-center, Phase 3 confirmatory clinical trial.
963 studies on the registry are indexed under Intestinal Diseases; 174 are open to participants now.
This study's planned enrollment of 110 is above the median of 70 across 552 interventional studies indexed under Intestinal Diseases.
Browse Intestinal Diseases studies →Pharmbio Korea Co., Ltd. is the lead sponsor of 9 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
PBK\_M2502, 1-Day Regimen
Drug: PBK_M2502 1-Day
PBK\_M2502, 2-Day Regimen
Drug: PBK_M2502 2-Day
Subjects who are randomized into group test 2 will receive bowel preparation on the same-day.
Subjects who are randomized into group test 1 will receive bowel preparation from evening to next morning.
Successful cleansing rate
%Patient with HCS-graded A or B
Time frame: Day 1 (day of colonoscopy)
Overall cleansing rate
%Patient with each HCS-grade (A, B, C, D)
Time frame: Day 1 (day of colonoscopy)
Mean segmental cleansing score
5 Segment: Rectum, Sigmoid colon, Descending colon, Transverse colon, Ascending colon/cecum.
Time frame: Day 1 (day of colonoscopy)
Mean cecal intubation time
Time frame: Day 1 (day of colonoscopy)
Mean colonoscopy withdrawal time
Time frame: Day 1 (day of colonoscopy)
Treatment compliance
Dosage taken/Dosage scheduled
Time frame: Day 1 (day of colonoscopy)
Patient satisfaction
Subject questionnaire (Taste, Difficulty, Ease of taking)
Time frame: Day 1 (day of colonoscopy)
Polyp detection rate
Time frame: Day 1 (day of colonoscopy)
This study is not yet recruiting, as verified in May 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pharmbio Korea Co., Ltd.